How to expedite early-phase SARS-CoV-2 vaccine trials in pandemic setting-A practical perspective

Br J Clin Pharmacol. 2021 May;87(5):2167-2169. doi: 10.1111/bcp.14435. Epub 2020 Jun 30.

Authors

Johan L van der Plas^{1

2}, Meta Roestenberg^{2

3}, Adam F Cohen¹, Ingrid M C Kamerling^{1

2}

Affiliations

¹ Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
² Department of Infectious Diseases, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.
³ Department of Parasitology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.

No abstract available

Publication types

Editorial

MeSH terms

COVID-19 / prevention & control*
COVID-19 Vaccines*
Clinical Trials as Topic / organization & administration*
Humans
Pandemics*

Substances

COVID-19 Vaccines